Citation Impact
Citing Papers
Diabetes and Cardiovascular Disease
1999 Standout
Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Microalbuminuria Collaborative Study Group, United Kingdom.
1993
Piezo1 and Piezo2 Are Essential Components of Distinct Mechanically Activated Cation Channels
2010 StandoutScienceNobel
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy
1982
Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes
1983
Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
1988
Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study.
1985
Stabilization and regression of albuminuria in Chinese patients with type 2 diabetes: A one-year randomized study of valsartan versus enalapril
2005
AGEs and Diabetic Retinopathy
2010
Predisposition to Hypertension and Susceptibility to Renal Disease in Insulin-Dependent Diabetes Mellitus
1988
Antihypertensive agents for preventing diabetic kidney disease
2005
Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy
2002
Shared genetic susceptibility of Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus: contributions of HLA and haptoglobin
1991
Hyaluronan Metabolism in Skin
1994
Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study
1996
Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy
2001
Microalbuminuria in prediction and prevention of diabetic nephropathy in insulin-dependent diabetes mellitus patients
1995
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus
1997
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
2000 StandoutNature
A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly
2003
Prevalence of microalbuminuria, arterial hypertension, retinopathy, and neuropathy in patients with insulin dependent diabetes
1988
Treatment of arterial hypertension in diabetic humans: Importance of therapeutic selection
1992
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
2012
Short and long term effects of antihypertensive therapy in the diabetic rat
1989
Baseline characteristics of participants in the appropriate blood pressure control in diabetes trial
1996
The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes
2001 Standout
Minireview: Computer Simulations of Blood Pressure Regulation by the Renin-Angiotensin System
2003 StandoutNobel
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL
2004
Urinary albumin excretion — A predictor of risk of cardiovascular disease A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men
1996
More Informative Abstracts Revisited
1990
Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM)
2002
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Familial Clustering of Cardiovascular Disease in Patients with Insulin-Dependent Diabetes and Nephropathy
1992
Renal handling of albumin: A critical review of basic concepts and perspective
2002
A Taql polymorphism in the human interleukin‐1β (IL‐1β) gene correlates with IL‐1β secretion in vitro
1992
Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study
2002
Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study
1994
MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS
1988
Angiotensin converting enzyme gene polymorphisms and renal disease
1998
High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells.
1998
Drug Treatment for Hypertensive Patients in Special Situations: Diabetes and Hypertension
1999
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study
1995 Standout
Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.
1996
Diabetic nephropathy—What are the unmet needs?
2008
Appropriate Blood Pressure Control in NIDDM (ABCD) Trial
1996
High-normal blood pressure and microalbuminuria
2003
Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria
2002
Long-Term Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Patients With Nephrotic Proteinuria
1992
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects
1994
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
2010
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
2002
Diabetes in Asia
2009 Standout
Role of Remission Clinics in the Longitudinal Treatment of CKD
2008
Effect of 5-year enalapril therapy on progression of microalbuminuria and glomerular structural changes in type 1 diabetic subjects
2003
Relation between albumin in the urine and electrocardiographic markers of myocardial ischemia in patients without diabetes mellitus
2001
Microalbuminuria and ACE inhibition in non-hypertensive diabetics
1990
Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients
2001
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
1998
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Determinants of end-stage renal disease in Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus and proteinuria
1993
Evaluation of a simple, random urine test for prospective analysis of proteinuria in Type 2 diabetes: a six year follow-up study
2000
Endothelial dysfunction and pathogenesis of diabetic angiopathy
1997
Effects of perindopril on renal histomorphometry in diabetic subjects with microalbuminuria: A 3-year placebo-controlled biopsy study
1998
Global and societal implications of the diabetes epidemic
2001 StandoutNature
Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria
2001
Angiotensin-converting enzyme 2 protects from severe acute lung failure
2005 StandoutNature
Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study
1995
Transmembrane Pickets Connect Cyto- and Pericellular Skeletons Forming Barriers to Receptor Engagement
2018 StandoutNobel
Microalbuminuria and Endothelial Dysfunction: Emerging Targets for Primary Prevention of End-organ Damage
2006
Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients*
1995
Long-Term Complications of Diabetes Mellitus
1993 Standout
Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study
2000
The Effects of Improved Glycemic Control on Complications in Type 2 Diabetes
1998
Intrarenal hemodynamic abnormalities in diabetic nephropathy measured by duplex Doppler sonography
1997
Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance
1998
Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: A twenty-three year follow-up study
1992
The hormone resistin links obesity to diabetes
2001 StandoutNature
Prevention of diabetic renal disease with special reference to microalbuminuria
1995
Consequences of alteration in capillary permeability
1996
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
1998
Usefulness of Microalbuminuria in Predicting Cardiovascular Mortality in Treated Hypertensive Men With and Without Diabetes Mellitus
1997
Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity
2001
Glycemic control and cardiovascular disease in Type 2 diabetes: a review
1999
The Hallmarks of Aging
2013 Standout
Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study
2000
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
1993 Standout
The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria
1995
Morbidity in 565 Type 2 Diabetic Patients According to Stage of Nephropathy
1998
Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study
2002
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Possible effect of angiotensin-converting enzyme inhibition on glomerular charge selectivity
1995
Low testosterone and anaemia in men with type 2 diabetes
2008
Familial Clustering of Diabetic Kidney Disease
1989
Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus
1990
Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril
1989
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Lisinopril reduces albuminuria during exercise in low grade microalbuminuric Type 1 diabetic patients: a double blind randomized study
2001
Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy
2002
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Prognostic Value of Angiotensin-I Converting Enzyme I/D Polymorphism for Nephropathy in Type 1 Diabetes Mellitus
2001
Epidemiological Evidence for the Association of Hyperglycaemia and Atherosclerotic Vascular Disease in Non-insulin-dependent Diabetes Mellitus
1996
Nephropathy in Patients with Type 2 Diabetes Mellitus
1999
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
Pre-diabetic blood pressure predicts urinary albumin excretion after the onset of Type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians
1993
Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus
2001
Blood Pressures and Cardiovascular Homeostasis in Mice Having Reduced or Absent Angiotensin-Converting Enzyme Gene Function
1997 StandoutNobel
Antihypertensive agents for preventing diabetic kidney disease
2012
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Proteinuria in diabetes mellitus: Role of spontaneous and experimental variation of glycemia
1982
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis
2010
The Risk of Cardiovascular Disease Mortality Associated With Microalbuminuria and Gross Proteinuria in Persons With Older-Onset Diabetes Mellitus
2000
EFFECT OF TWO YEARS OF STRICT METABOLIC CONTROL ON PROGRESSION OF INCIPIENT NEPHROPATHY IN INSULIN-DEPENDENT DIABETES
1986
External detection and visualization of myocardial ischemia with 11C-substrates in vitro and in vivo.
1976
Coronary Artery Disease in IDDM
1996
Incipient nephropathy in Type 1 (insulin-dependent) diabetes
1984
Progression of Nephropathy in Long-Term Diabetics with Proteinuria and Effect of Initial Anti-Hypertensive Treatment
1976
Functional rafts in cell membranes
1997 StandoutNature
Non-insulin-dependent diabetes in older patients
1986
Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study
2003
Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease
2001
Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality, Cardiovascular Deaths, and Cardiovascular Events in Patients With Diabetes Mellitus
2014
Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor
2004 StandoutNobel
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse
2001 StandoutNobel
Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus
2004 Standout
Effect of protein restriction in insulin dependent diabetics at risk of nephropathy.
1987
Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.
1986
Microalbuminuria and Peripheral Arterial Disease Are Independent Predictors of Cardiovascular and All-Cause Mortality, Especially Among Hypertensive Subjects
1999
Reduction of ACE Activity Is Insufficient to Decrease Microalbuminuria in Normotensive Patients With Type 1 Diabetes
2001
Protein kinase C activation and the development of diabetic complications.
1998
The Early Natural History of Nephropathy in Type 1 Diabetes
2002
Angiotensin-Converting Enzyme Gene and Atherosclerosis
1997 StandoutNobel
Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease
2012
ACE-I and ARBs in early diabetic nephropathy
2002
Natural history of nephropathy in type I diabetes. Relationship to metabolic control and blood pressure.
1985
Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus.
1987
Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy.
1985 Standout
Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.
1994
Left ventricular mass index increases in proportion to the progression of diabetic nephropathy in Type 2 diabetic patients
2001
Positron Tomography and Nuclear Magnetic Resonance Imaging
1982 StandoutScienceNobel
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease
2006
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 Standout
A genetically clamped renin transgene for the induction of hypertension
2002 StandoutNobel
Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
1996
Effects of Treatment Targets on Subsequent Cardiovascular Events in Chinese Patients With Type 2 Diabetes
2007
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
2001 Standout
Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria.
1987
Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease
2001
Effect of antihypertensive treatment on kidney function in diabetic nephropathy.
1987
Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner
1998 StandoutNobel
Structural-functional relationships in diabetic nephropathy.
1984 Standout
Why the kidney glomerulus does not clog: A gel permeation/diffusion hypothesis of renal function
2003 StandoutNobel
Genetic Dissection of Complex Traits
1994 StandoutScience
Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothelium: receptor-mediated transcytosis.
1986
Elevated Urinary Albumin Excretion Is Associated With Impaired Arterial Dilatory Capacity in Clinically Healthy Subjects
2001
Microalbuminuria and Carotid Artery Intima-Media Thickness in Nondiabetic and NIDDM Subjects
1997
Predicting Diabetic Nephropathy in Insulin-Dependent Patients
1984
Serum Creatinine as an Index of Renal Function: New Insights into Old Concepts
1992 Standout
More Informative Abstracts Revisited
1991
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 Standout
Nephron adaptation to renal injury or ablation
1985
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
Angiotensin-Converting Enzyme Gene Mutations, Blood Pressures, and Cardiovascular Homeostasis
1997 StandoutNobel
Microalbuminuria as a Risk Predictor in Diabetes: The Continuing Saga
2014
Effect of Control of Blood Glucose on Urinary Excretion of Albumin and β2Microglobulin in Insulin-Dependent Diabetes
1979
Glomerular structural changes in Type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention
1992
Kidney volume in type 1 (insulin-dependent) diabetic patients with normal or increased urinary albumin excretion: effect of long-term improved metabolic control
1991
Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy
1986
Effects of Fosinopril and Pravastatin on Cardiovascular Events in Subjects With Microalbuminuria
2004
Monitoring glomerular function in diabetic nephropathy
1983
Hyperinsulinemic Microalbuminuria
1995
Increased Urinary Albumin Excretion, Endothelial Dysfunction, and Chronic Low-Grade Inflammation in Type 2 Diabetes
2002
Critical Role for Transient Receptor Potential Channel TRPM4 in Myogenic Constriction of Cerebral Arteries
2004
Urinary Albumin Excretion as a Predictor of Diabetic Retinopathy, Neuropathy, and Cardiovascular Disease in NIDDM
1996
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
1993 Standout
EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHY
1983
Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
2000
Hematocrit, Independent of Chronic Kidney Disease, Predicts Adverse Cardiovascular Outcomes in Chinese Patients With Type 2 Diabetes
2006
Proteinuria Predicts Stroke and Other Atherosclerotic Vascular Disease Events in Nondiabetic and Non–Insulin-Dependent Diabetic Subjects
1996
Pathomorphologic aspects of muscular tissue in diabetes mellitus
1984
The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies
1982
Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes
1984 Standout
Dietary Protein Intake and the Progressive Nature of Kidney Disease:
1982 Standout
Works of H.‐H. Parving being referenced
Prognosis in diabetic nephropathy.
1989
Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.
1988
Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy.
1989
The course of kidney function in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy
1993
Plasma concentrations of VCAM‐1 and ICAM‐1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy
2000
Insertion/deletion polymorphism in the angiotensin-l-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy
1995
Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients
1991
Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive Type 1 (insulin-dependent) diabetic patients with background retinopathy
1989
Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy
1999
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials
2011
Left Ventricular Hypertrophy in Non-insulin-dependent Diabetic Patients With and Without Diabetic Nephropathy
1997
Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspective
2006
Anaemia in diabetes: is there a rationale to TREAT?
2006
Renoprotection in diabetes: genetic and non-genetic risk factors and treatment
1998
Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy
1992
Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy
1997
Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study
1996
The Selective Vitamin D Receptor Activator for Albuminuria Lowering (VITAL) Study: Study Design and Baseline Characteristics
2009
Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria
1999
Glomerular size-and charge selectivity in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy
1994
Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy
2004
Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design
2009
Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment
1994
The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics
1976
Hemodynamic factors in the genesis of diabetic microangiopathy
1983
Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria
2004
INCREASED URINARY ALBUMIN-EXCRETION RATE IN BENIGN ESSENTIAL HYPERTENSION
1974
Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.
1986
Prevalence of microalbuminuria in children with Type 1 (insulin-dependent) diabetes mellitus
1986
Reduction in albuminuria predicts diminished progression in diabetic nephropathy.
1994
Clinical Physiology: Increased Metabolic Turnover Rate and Transcapillary Escape Rate of Albumin in Long-Term Juvenile Diabetics
1975
Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion
1982
Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.
1991
Transcapillary escape rate of albumin and right atrial pressure in chronic congestive heart failure before and after treatment.
1976
Renal function in streptozotocin-diabetic rats
1981
Effects of indomethacin on kidney function in Type 1 (insulin-dependent) diabetic patients with nephropathy
1987
The effect of glucagon infusion on kidney function in short-term insulin-dependent juvenile diabetics
1980
Effect of intravenous glucose infusion on renal function in normal man and in insulin-dependent diabetics
1981
Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries.
1999
Acute reduction of arterial blood pressure reduces urinary albumin excretion in Type 1 (insulin-dependent) diabetic patients with incipient nephropathy
1986
A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy
1981
Impaired autoregulation of cerebral blood flow in long‐term Type I (insulin‐dependent) diabetic patients with nephropathy and retinopathy
1986
Albuminuria and poor glycemic control predict mortality in NIDDM
1995
Glomerular structure and function in proteinuric Type 2 (non-insulin-dependent) diabetic patients
1993
The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus
1981
Lack of familial predisposition to cardiovascular disease in Type 1 (insulin-dependent) diabetic patients with nephropathy
1991
Impaired autoregulation of glomerular filtration rate in Type 1 (insulin-dependent) diabetic patients with nephropathy
1984
Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy.
1985
Diabetic nephropathy and arterial hypertension
1983
HLA associations in insulin‐dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population
1986
Kidney function and size in normal subjects before and during growth hormone administration for one week
1981
Transcapillary Escape Rate of Albumin and Plasma Volume in Short- and Long-Term Juvenile Diabetics
1973
The effect of 1-thyroxine treatment on skin accumulation of acid glycosaminoglycans in primary myxoedema
1986
Filtration as the main mechanism of overall transcapillary protein escape from the plasma
1974
Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics
1981
Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.
2000